The DClinDent in Oral Surgery is a three-year, full-time programme which will allow the candidate to achieve specialist-level training in oral surgery, together with a taught professional Doctorate, preparing them for the Speciality examination of Membership in Oral Surgery (MOralSurg) of the Royal Colleges of Surgeons (Tricollegiate Edinburgh, Glasgow, England) UK.
The DClinDent aims to provide doctoral level educational opportunities to enable students to develop, consolidate and enhance their range of academic and clinical competencies to enable independent and reflective practice at the standard of a specialist in oral surgery.
This programme is for dental surgery graduates who wish to extend their knowledge, clinical practice experience and expertise in oral surgery.
The programme will give you theoretical and practical understanding of oral surgery and how it relates to other dental specialities.
The syllabus components are based on the core competencies for oral surgery training as set out by Specialty Advisory Committee (SAC) for Oral Surgery, The Faculty of Dental Surgery The Royal College of Surgeons of England (2014) :
For Year 1 and Year 2 students, there will be a written exam at the end of each term.
In addition to the above, at the end of Year 2, students will also have oral exams in June and in August/September.
Successful completion of the first two years of the programme will allow students to proceed to Year 3 of the programme. In Year 3, students will present the following:
a) a clinical governance project b) a systematic review of a topic related to Oral Surgery c) two fully documented patient case presentations d) two unseen (diagnostic) cases will also form part of this examination
The third year of the DClinDent programme will be structured over three semesters and during this time the student will be timetabled to four protected academic sessions each week with the remaining time dedicated to primarily independent clinical practice and inter-disciplinary patient management.
Year 1 courses:
Year 2 courses:
Year 3 courses:
This programme has been designed for dental surgery graduates who wish to specialise in oral surgery.
Our one-year MSc Oral and Maxillofacial Surgery course is designed for dentists who wish to advance their knowledge of this clinical specialty at postgraduate level.
This specialty is concerned with the diagnosis and management of diseases, injuries and defects affecting the mouth, jaws, face and neck.
The specialist clinical component of the course will give you an understanding of the scientific basis of oral and maxillofacial surgery, with particular emphasis on current theories relevant to the diagnosis, treatment planning and clinical management of patients. The course will also emphasise the evidence base supporting clinical surgical practice.
You will observe a wide range of surgery, including facial trauma, implant and reconstructive, cancer and reconstructive, salivary gland and orthognathic surgery, as well as participating in dentoalveolar surgery.
The course also covers the design, data collection, and simple analysis and interpretation of clinical research projects, and culminates in the MSc dissertation. You will learn how to identify, formulate and implement a specific research project in line with the research themes of pain and anxiety control, surgical implantology, or oral cancer and health services research.
The course aims to provide dental practitioners with the knowledge and skills to undertake minor oral surgery in the context of a wider knowledge of oral and maxillofacial surgery.
Our teaching and learning methods are designed to encourage you to take responsibility for your own learning and to integrate work with formal educational activities.
We will provide the core text book for the course. This book, Master Dentistry Oral and Maxillofacial Surgery, Radiology, Pathology and Oral Medicine (ISBN 0443061920), has been authored by University staff Coulthard, Horner, Sloan and Theaker.
Assessment is by essay and SBAs throughout the course and related to the taught units. You will also maintain a clinical surgical logbook and undertake a clinical competency test. There is also an oral examination.
The Specialist Clinical component consists of the following modules:
The MSc includes a research project and dissertation.
Examples of dissertations submitted include:
You will have access to dedicated postgraduate suites. You will also be able to access a range offacilities throughout the University.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service .
We will invite you to participate in a number of conferences and courses. Some selected seminars will also provide you with CPD hours.
This course will prepare you for a future career in clinical practice, teaching or research.
Some graduates return to established surgical practice, while others go on to the next step in their training and pursue specialist clinical training and appropriate clinical examinations in oral and maxillofacial surgery.
Graduates may find their advanced knowledge a good foundation for surgical dentistry, oral surgery or oral and maxillofacial surgery practice. Some graduates proceed to undertake higher research degrees such as a PhD.
The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. The programme, taught by research scientists and academic clinicians, provides students with an in-depth look at the biology behind the disease processes which lead to cancer.
This programme offers a foundation in understanding cancer as a disease process and its associated therapies. Students learn about the approaches taken to predict, detect, monitor and treat cancer, alongside the cutting-edge research methods and techniques used to advance our understanding of this disease and design better treatment strategies.
Students undertake modules to the value of 180 credits.
The programme consists of two core modules (60 credits), four specialist modules (60 credits) and a research project (60 credits).
A Postgraduate Diploma (120 credits, full-time nine months) is offered.
A Postgraduate Certificate (60 credits, full-time 12 weeks) is offered.
All MSc students undertake a laboratory project, clinical trials project or systems biology/informatics project, which culminates in a 10,000–12,000 word dissertation and an oral research presentation.
Teaching and learning
Students develop their knowledge and understanding of cancer through lectures, self-study, database mining, wet-lab based practicals, clinical trial evaluations, laboratory training, assigned reading and self-learning. Each taught module is assessed by an unseen written examination and/or coursework. The research project is assessed by the dissertation (75%) and oral presentation (25%).
Further information on modules and degree structure is available on the department website: Cancer MSc
The knowledge and skills developed will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating a PhD or medical studies in cancer.
Skills include critical evaluation of scientific literature, experimental planning and design interpretation of data and results, presentation/public speaking skills, time management, working with a team, working independently and writing for various audiences.
UCL is one of Europe's largest and most productive centres of biomedical science, with an international reputation for leading basic, translational and clinical cancer research.
The UCL Cancer Institute brings together scientists from various disciplines to synergise multidisciplinary research into cancer, whose particular areas of expertise include: the biology of leukaemia, the infectious causes of cancer, the design of drugs that interact with DNA, antibody-directed therapies, the molecular pathology of cancer, signalling pathways in cancer, epigenetic changes in cancer, gene therapy, cancer stem cell biology, early phase clinical trials, and national and international clinical trials in solid tumours and blood cancers.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Cancer Institute
80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies.
You will learn how to master experimental cancer through a combination of traditional teaching and hands-on learning, spending a year as a member of the Experimental Cancer Medicine Team at The Christie while also taking four structured taught units.
The taught units will see you learn the details of designing and delivering Phase 1 clinical studies, understanding the pre-clinical data required before a clinical programme can commence, and how to optimise early clinical studies to provide evidence for progressing a promising drug into Phase II/III clinical testing.
Alongside the taught elements, you will be allocated to one or more clinical trials that are being conducted by The Christie experimental cancer medicine team. You will have a named trainer and be exposed to tasks required in the setup, delivery, interpretation and audit of a clinical study.
Nursing and physician students will be expected to participate in patient care, including new and follow-on patient clinics, treatment and care-giving episodes with patients.
For clinical trials coordinators, no direct patient contact is envisaged and duties will involve clinical trial setup, protocol amendments, database setup, data entry, costing and billing for clinical research.
You will be able to choose two aspects of your direct clinical trial research experience to write up for your two research projects in a dissertation format. This will give you the skills and knowledge required to critically report medical, scientific and clinically related sciences for peer review.
The primary purpose of the MRes in Experimental Cancer Medicine is to provide you with the opportunity to work within a premier UK Phase 1 cancer clinical trials unit and, through a mix of taught and experiential learning, master the discipline of Experimental Cancer Medicine.
Extensive practical experience
You will spend most of your time gaining hands-on experience within The Christie's Experimental Cancer Medicine Team.
Meet the course team
Dr Natalie Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie. She completed a PhD at Cambridge, investigating translational therapeutics and biomarker assay design in pancreatic cancer.
Professor Hughes is Chair of Experimental Cancer Medicine at the University and Strategic Director of the Experimental Cancer Medicine team at The Christie. He is a member of the research strategy group for Manchester Cancer Research Centre. He serves on the Biomarker evaluation review panel for CRUK grant applications.
Professor Hughes was previously Global Vice-President for early clinical development at AstraZeneca, overseeing around 100 Phase 0/1/2 clinical studies. He was previously Global Vice-President for early phase clinical oncology, having been involved in over 200 early phase clinical studies.
Dr Matthew Krebs is a Clinical Senior Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie.
He has a PhD in circulating biomarkers and postdoctoral experience in single cell and ctDNA molecular profiling. He is Principal Investigator on a portfolio of phase 1 clinical trials and has research interests in clinical development of novel drugs for lung cancer and integration of biomarkers with experimental drug development.
Our course is structured around a 2:1 split between clinical-based research projects and taught elements respectively.
Taught course units will predominantly use lectures and workshops.
For the research projects, teaching and learning will take place through one-to-one mentoring from a member of the Experimental Cancer Medicine team.
The clinical and academic experience of contributors to this course will provide you with an exceptional teaching and learning experience.
You will be assessed through oral presentations, single best answer exams, written reports and dissertation.
For each research project, you will write a dissertation of 10,000 to 15,000 words. Examples of suitable practical projects include the following.
Publication-based/dissertation by publication
Service development/professional report/ report based dissertation
Adapted systematic review (qualitative data)
Full systematic review that includes data collection (quantitative data)
Qualitative or quantitative empirical research
Qualitative secondary data analysis/analysis of existing quantitative data
Quantitative secondary data analysis/analysis of existing qualitative data/theoretical study/narrative review
Teaching will take place within The Christie NHS Foundation Trust , Withington.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service. Email: [email protected]
This course is relevant to physician, nursing and clinical research students who are considering a career in Phase 1 clinical studies.
The course provides a theoretical and experiential learning experience and offers a foundation for roles within other experimental cancer medicine centres within the UK and EU, as well as careers in academia, the pharmaceutical industry, clinical trials management and medicine.
The MRes is ideal for high-calibre graduates and professionals wishing to undertake directly channelled research training in the clinical and medical oncology field.
This course will enhance your knowledge and understanding of cancer therapies and provide you with the skills to assess, analyse, critically appraise and evaluate current and emerging anti-cancer therapies and the drug discovery cascade, from target evaluation and engagement to clinical trials.
The programme was developed in response to the increasing demand for a course which focuses on current and emerging cancer therapies. It is the only programme in the UK which combines a focus on cancer biology with the practical, ethical and economic implications of personalised cancer therapy, along with its biology and the discovery and development of drugs.
It has been constructed to produce world-class graduates with the skills to contribute to the global drive in advancing cancer treatment through research, teaching, industry and public sector employment.
You'll focus on anti-cancer treatment therapies, with a particular emphasis on personalised medicine, covering the therapeutic target and the biological mechanisms of current and emerging anti-cancer therapies. You'll also explore radiotherapy as a diagnostic and as a single or combinational treatment with drugs in anti-cancer therapy.
You'll be introduced to the discovery and development of new drugs and the challenges associated with this process. You'll be able to evaluate the drug discovery pipeline including medicinal chemistry, screening, secondary assays and other drug discovery and development technologies. Through a virtual drug discovery programme, you'll have the opportunity to develop anti-cancer agents and progress these through the drug discovery cascade, from target engagement to clinical trials.
The programme will equip you with a range of skills including scientific writing, critical analysis, problem-solving, teamworking, as well as advanced data set analysis and interpretation. You'll experience a wide range of scientific topics from molecular biology, to cell biology and genetics, medicinal chemistry to formulation and radiobiology to nuclear medicine. You'll have the opportunity to conduct independent research and working as part of a multidisciplinary team you'll gain an appreciation of the contributions other disciplines make to cancer drug discovery.
The Strathclyde Institute of Pharmacy & Biomedical Sciences is recognised as one of the foremost departments of its kind in the UK. It's a leading research centre in the search for new and improved medicines. You'll benefit from the advanced facilities of a new £36 million building. The Institute is ranked no 2 in the UK in the Complete University Guide 2018 and the University of Strathclyde has recently been one of the few UK institutes to be awarded the status of 'Emerging Centre of excellence for radiobiology research' in the UK.
The course is delivered through lectures, workshops, tutorials and hands-on practical sessions.
If you successfully complete the required taught classes you may undertake a laboratory project on the subject of cancer therapies for the MSc.
Written examinations, course work with formative and summative approaches are taken in different aspects of the course. Written reports, oral presentations, scenario-based learning and moderated peer assessment are all included in the course.
Graduates will have a number of potential employment opportunities: large and small pharma companies, SMEs, within health services and providers, their home institutions and as academics in UK, EU or international Universities.
The course will enable careers in research, academia industry and the health sector and offers you a unique exposure to the entire drug discovery and development cascade while keeping patients' needs at the forefront of the learning process.
Our MRes Oncology course will enable you to develop the skills and knowledge you need to prepare for a career in cancer research.
Cancer is a major cause of mortality and morbidity worldwide. Approximately 300,000 people develop the disease each year in the UK.
Understanding the basis of tumourigenesis and developing new therapies are high priority areas for investment, especially since the economic burden of cancer is increasing. The field of oncology encompasses a wide variety of biological and physical sciences.
You will learn from renowned basic, translational and clinical scientists at the Manchester Cancer Research Centre, the Cancer Research UK (CRUK) Manchester Institute and The Christie NHS Foundation Trust, with a focus on developing practical research skills.
Our course covers the clinical and research aspects of cancer care, and you will have access to an exceptionally wide range of research projects in basic cancer biology, translational areas and clinical cancer care and imaging.
This MRes has both taught and research components and is suitable for those with little or no previous research experience.
Our MRes course aims to provide postgraduate level training that will equip you with the specialist knowledge and research skills to pursue a research career in the fields of medical and clinical oncology.
You will gain an understanding of the scientific basis of cancer and its treatments, as well as the skills needed to evaluate the potential efficacy of new treatments.
This course also offers the potential to:
Clinical and research components
This is one of only a handful of MRes Oncology courses in the UK. Unlike many other oncology courses, ours has both clinical and research elements, making it suitable for both medical undergraduates and graduates, as well as biomedical science graduates.
Our MRes is structured around a 2:1 split between laboratory/clinical-based research projects and taught elements.
Laboratory and clinical research experience is gained through two research placements, one lasting approximately ten weeks (October to December) and the second lasting approximately 25 weeks (January to August).
You may choose to carry out one project for both placements, which most students do, or separate projects for each placement.
Most research placements are based at the Christie site, either within the hospital, the Manchester Cancer Research Centre or CRUK Manchester Institute premises. Projects are also available on the Central Manchester University Hospitals and University Hospital of South Manchester sites.
A list of available projects will be provided to offer holders in August.
Students are assessed through oral presentations, single best answer exams, written reports and a dissertation.
The course features the following components:
The Research Methods course unit covers topics relating to:
The Clinical Masterclass course unit provides a truly multidisciplinary foundation in the key issues in oncology. Delivery is by lectures and site tours and these classes will offer the student the chance to debate with internationally recognised experts in their field. Areas covered include:
Following attendance at these classes, you will be able to understand how cancer is diagnosed and the principles of cancer surgery, radiotherapy and chemotherapy.
The Lecture Series course unit comprises two intensive one-week courses, one in November and the other in February. The November course covers the biological basis of chemotherapy, pharmacology and cancer biology. The February course covers the biological basis of radiotherapy and translational aspects of cancer research, including biomarkers and new technologies.
The Tutorial course unit allows students to choose from a selection of clinical and academic oncology topics. The unit aims to improve ability to interpret and criticise literature as well as improve verbal communication skills in a small group setting.
This new and innovative course builds upon the integrated nature of the School of Dentistry’s clinical and basic science divisions, and aims to prepare future researchers, from scientific or clinical backgrounds for research careers based in addressing oral health needs. You’ll gain a thorough background in oral sciences, the investigative, cutting edge technologies that enable oral scientific discovery and the necessary training in research governance and rigour. All areas of translational research pathways will be addressed, including aspects of commercialisation which will be taught through the Leeds University Business School (LUBS). Disease focused modules provide opportunities for in-depth exploration with research experts in the fields of Cancer, Musculoskeletal and Oral and systemic disease links.
Our teaching staff includes world leading experts with track records in translating research discoveries into novel healthcare products and practices. Student integration within the wider Dental school will be facilitated by undertaking recently updated modules shared with students from other MSc programmes.
Aimed at dental and biosciences graduates, the course will facilitate a career path focussed on oral research and its translation into positive impacts on health.
The programme will:
Teaching will be split between the Dental school on the main campus and the Wellcome Trust Brenner Building (WTBB) at the St James’s University Hospital. The WTBB is a modern purpose built research facility, housing cutting edge facilities in imaging, tissue and microbiological culture and next generation sequencing technologies. On the main campus students can benefit from all the expertise, facilities (such as the Leeds Dental Translational and Clinical Research Unit) and support provided by the Dental school.
Our course emphasises student directed and multidisciplinary learning. Teaching methods include lectures, seminars and workshops, complemented by e-learning and will be delivered by research active scientists and clinicians with additional input from industrial partners and Leeds University Business School (LUBS) academics.
Summative assessment will provide you with on-going feedback on your depth of subject knowledge and skills. Assessment methods for formative and summative assessment will include oral and poster presentations, unseen examinations and literature reviews. Exercises to identify research questions formulate research plans and prepare mock applications for funding and ethical/ governance approvals will also contribute to assessment.
You will gain insight into all stages of translational research, preparing you for a career working across multi-disciplinary teams within research and innovation management. The course aims to enhance your career prospects of securing PhD studentship positions, whether that be in pre-clinical or clinical research.
The innovation management in practice module enables you to learn about the commercial aspects of translational research. It may be that you want to go into the oral healthcare industry, so knowledge of business skills will be a useful transferable skill.
You may want to go into academic teaching positions within your own country; this MSc will provide the knowledge required to teach oral biology at undergraduate level.
Our MSc in Cancer Biology and Radiotherapy Physics is ideal if you wish to pursue a career in cancer research and/or cancer therapy involving ionising radiation.
With around 40% of all cancer cure cases involving radiotherapy and the UK soon to have a proton therapy service, the need for multidisciplinary scientists in this field has never been greater.
We aim to develop multidisciplinary scientists to create the necessary skill base that will drive radiotherapy forward in the UK.
This course will enable you to train as a multidisciplinary scientist in this area by covering a variety of subjects in content that is delivered by staff with a range of expertise, including physicists, biologists, engineers, clinicians and oncologists.
Our collaboration with The Christie will allow you to undertake unique research projects in its radiotherapy facilities that cannot be carried out anywhere else in the UK or most of Europe.
This course aims to help you develop:
You will be taught by academics from the University and clinical scientists at The Christie, meaning both fundamental science and its clinical application will be covered equally.
Units are delivered in one-week blocks with a mix of face-to-face content delivery and hands-on practical sessions.
There will be a number of assessed and non-assessed activities to develop your key skills and expand your knowledge base.
There is an also online pre-course element, which will be the beginning of your multidisciplinary scientific journey.
After the taught units, there is an supervised research project that will put into practice the key skills and knowledge acquired in the taught component.
The taught units will be assessed through multiple choice exams and practical assessments.
The research project will be assessed through the submission of a short report and oral presentation.
The taught component, which includes the five core and three optional units, will amount to 120 credits of the 180 credits required for an MSc qualification.
The remaining 60 credits will be obtained through a supervised research project.
Much of the course content is delivered through a collaboration with The Christie .
Our collaboration with The Christie means you will have access to an MRI image guided radiotherapy linear accelerator and a proton therapy centre incorporating a dedicated research room for your research project.
You will also be able to access a range of library and IT facilities throughout the University.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service .
Individual taught units from this MSc can be offered to industry and healthcare professionals as part of a career and professional development programme. Please contact us for further information.
This course will help you gain the knowledge and skills to become a leading healthcare scientist in the public or private sector.
It may also be of interest if you are a healthcare worker in the field of radiotherapy who wishes to advance your career.
The master's qualification gained could act as a stepping stone to further academic qualifications or careers involving medical science research.